- Home
- KIO vs NGNE Comparison
KIO vs NGNE Comparison
Compare KIO & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIO
- NGNE
- Stock Information
- Founded
- KIO 2011
- NGNE 2003
- Country
- KIO United States
- NGNE United States
- Employees
- KIO 2400
- NGNE N/A
- Industry
- KIO Investment Managers
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- KIO Finance
- NGNE Health Care
- Exchange
- KIO Nasdaq
- NGNE Nasdaq
- Market Cap
- KIO 404.1M
- NGNE 352.4M
- IPO Year
- KIO N/A
- NGNE N/A
- Fundamental
- Price
- KIO $13.02
- NGNE $22.64
- Analyst Decision
- KIO
- NGNE Strong Buy
- Analyst Count
- KIO 0
- NGNE 6
- Target Price
- KIO N/A
- NGNE $60.80
- AVG Volume (30 Days)
- KIO 136.5K
- NGNE 481.6K
- Earning Date
- KIO 01-01-0001
- NGNE 11-18-2024
- Dividend Yield
- KIO 10.82%
- NGNE N/A
- EPS Growth
- KIO N/A
- NGNE N/A
- EPS
- KIO N/A
- NGNE N/A
- Revenue
- KIO N/A
- NGNE $925,000.00
- Revenue This Year
- KIO N/A
- NGNE N/A
- Revenue Next Year
- KIO N/A
- NGNE N/A
- P/E Ratio
- KIO N/A
- NGNE N/A
- Revenue Growth
- KIO N/A
- NGNE N/A
- 52 Week Low
- KIO $10.52
- NGNE $14.41
- 52 Week High
- KIO $13.59
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- KIO 28.54
- NGNE 40.23
- Support Level
- KIO $13.56
- NGNE $21.34
- Resistance Level
- KIO $13.78
- NGNE $25.35
- Average True Range (ATR)
- KIO 0.14
- NGNE 2.14
- MACD
- KIO -0.04
- NGNE 0.88
- Stochastic Oscillator
- KIO 15.54
- NGNE 38.64
About KIO KKR Income Opportunities Fund
KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.